Process for manufacturing chewable dosage forms for drug delivery and products thereof
View Patent ↗A palatable, edible soft chewable medication vehicle for delivery of a pharmaceutically acceptable active ingredient, such as a drug, to an animal or human subject. The edible soft chews contain only food grade or better inactive ingredients, and preferably do not contain ingredients of animal origin. Processes for manufacturing the edible soft chews do not require the use of heat or the addition of water during mixing of active and inactive ingredients, provide stable concentrations of the active ingredient, and produce chews of consistent weight and texture.
1. A process for manufacturing an edible soft chewable medication comprising:
(a) blending an active ingredient with an oil and dry inactive ingredients including a flavoring, a binder, a bulking agent, a humectant and an excipient, wherein blending is performed at no more than about 10 °C. above room temperature;
(b) blending an anti-sticking agent selected from the group consisting of polyethylene glycol and paraffin wax with the blended ingredients of step (a) to form an edible soft chew mixture having a cookie dough-like texture; and
(c) molding the edible soft chew mixture into individual dosage units of the edible soft chewable medication without use of extrusion wherein the dosage units so formed are of consistent weight and active content from unit to unit.
2. The process of claim 1 , wherein the excipient comprises a starch, a cellulose, crospovidone, derivatives thereof, or a mixture thereof.
3. The process of claim 2 , wherein the excipient comprises starch.
4. The process of claim 3 , wherein the starch constitutes from about 15 to 50 percent (w/w) of the edible soft chewable medication.
5. The process of claim 1 , wherein the polyethylene glycol anti-sticking agent has an average molecular weight of about 3350 g/mol.
6. The process of claim 1 , wherein the polyethylene glycol anti-sticking agent constitutes from about 1 to 3 percent (w/w) of the edible soft chewable medication.
7. The process of claim 4 , wherein the polyethylene glycol anti-sticking agent constitutes from about 1 to 3 percent (w/w) of the edible soft chewable medication.
8. The process of claim 1 , wherein the active ingredient is selected from the group consisting of an anthelmetic, an analgesic, an antibiotic, an antiviral, an anti-inflammatory, an endoparasiticide, an ectoparasiticide, an antifungal, and combinations thereof.
9. The process of claim 1 , wherein the active ingredient comprises a non-steroidal anti-inflammatory.
10. The process of claim 1 , wherein the active ingredient comprises an antibiotic.
11. The process of claim 1 , wherein the active ingredient comprises ivermectin.
12. The process of claim 1 , wherein the active ingredient is coated.
13. The process of claim 1 , wherein the flavoring is a flavoring of non-animal origin.
14. The process of claim 1 , wherein the oil comprises soybean oil.
15. The process of claim 1 , wherein the humectant is selected from the group consisting of glycerol, propylene glycol, cetyl alcohol, and glycerol monostearate.
16. The process of claim 1 , wherein the dry inactive ingredients are of non-animal origin.
17. The process of claim 1 , further comprising preparing a trituration of the active ingredient with the excipient before the active ingredient is added to the dry inactive ingredients.
18. The process of claim 1 , further comprising forming an active suspension comprising a coated active ingredient and the oil prior to blending the active ingredient suspension with the dry inactive ingredients.
19. The process of claim 1 , wherein molding the edible soft chew mixture into individual dosage units comprises knocking out the edible soft chewable medication from a cavity of a mold plate.
20. The process of claim 1 , wherein molding the edible soft chew mixture into individual dosage units is performed at no more than 10° C. below room temperature.
21. The process of claim 1 , wherein blending of the active ingredient with the dry ingredients is performed at no more than 10° C. below room temperature.
22. The process of claim 1 , wherein the bulking agent comprises dicalcium phosphate.